Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia Reperfusion Injury
Background/Aims: Ischemia/reperfusion (I/R) injury is the main cause of both primary graft dysfunction and primary non-function of liver allografts. Cannabinoids has been reported to attenuate myocardial, cerebral and hepatic I/R oxidative injury. Delta-9-tetrahydrocannabinol (THC), a cannabinoid ag...
Main Authors: | Edith Hochhauser, Eylon Lahat, Maya Sultan, Orit Pappo, Maayan Waldman, Yosef Sarne, Asher Shainberg, Mordechai Gutman, Michal Safran, Ziv Ben Ari |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2015-07-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/430165 |
Similar Items
-
Studies of the anticonvulsant spectrum of delta 9 - tetrahydrocannabinol in rats
by: Reinking, Jeffrey Carl
Published: (1976) -
Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract
by: Joseph J. Wakshlag, et al.
Published: (2020-09-01) -
Acute human exposure assessment to tetrahydrocannabinol (Δ9‐THC)
by: European Food Safety Authority (EFSA), et al.
Published: (2020-01-01) -
Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?
by: Nancy De Briyne, et al.
Published: (2021-03-01) -
Sodium channel activation mechanisms : insights from deuterium oxide and delta-9-tetrahydrocannabinol substitution
by: Alicata, Daniel Andrew
Published: (2009)